These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

874 related articles for article (PubMed ID: 9272234)

  • 1. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate.
    Minato H; Kikuta C; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of the novel cerebrovascular-selective calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate on ischemic brain damage after permanent middle cerebral artery occlusion in rats.
    Minato H; Honda Y; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1996 Jun; 46(6):567-71. PubMed ID: 8767345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
    Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11 -yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate on cerebral vasospasm and impairment of cerebral circulation in subarachnoid hemorrhage model in rats.
    Honda Y; Minato H; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1996 Aug; 46(8):746-50. PubMed ID: 9125271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of cerebral infarction, apoptotic cell death and expression of X-chromosome-linked inhibitor of apoptosis protein following focal cerebral ischemia in rats.
    Xu XH; Zhang SM; Yan WM; Li XR; Zhang HY; Zheng XX
    Life Sci; 2006 Jan; 78(7):704-12. PubMed ID: 16139848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats.
    Campbell CA; Mackay KB; Patel S; King PD; Stretton JL; Hadingham SJ; Hamilton TC
    Exp Neurol; 1997 Nov; 148(1):45-50. PubMed ID: 9398449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia.
    Vakili A; Hosseinzadeh F; Sadogh T
    Brain Res; 2007 Sep; 1170():97-102. PubMed ID: 17698046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise preconditioning ameliorates inflammatory injury in ischemic rats during reperfusion.
    Ding YH; Young CN; Luan X; Li J; Rafols JA; Clark JC; McAllister JP; Ding Y
    Acta Neuropathol; 2005 Mar; 109(3):237-46. PubMed ID: 15616790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-ischemic treatment of pentoxifylline reduces cortical not striatal infarct volume in transient model of focal cerebral ischemia in rat.
    Vakili A; Zahedi khorasani M
    Brain Res; 2007 May; 1144():186-91. PubMed ID: 17320054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion.
    Sayeed I; Guo Q; Hoffman SW; Stein DG
    Ann Emerg Med; 2006 Apr; 47(4):381-9. PubMed ID: 16546625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective plasma concentration of a novel Na+/Ca2+ channel blocker NS-7 for its cerebroprotective actions in rats with a transient middle cerebral artery occlusion.
    Aoki Y; Tamura M; Itoh Y; Seto T; Nonaka K; Mukai H; Ukai Y
    J Pharmacol Exp Ther; 2001 Feb; 296(2):306-11. PubMed ID: 11160611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of edema and infarct volume following focal cerebral ischemia by early but not delayed administration of a novel small molecule KDR kinase inhibitor.
    Foster KA; Regan HK; Danziger AP; Detwiler T; Kwon N; Rickert K; Lynch JJ; Regan CP
    Neurosci Res; 2009 Jan; 63(1):10-6. PubMed ID: 18951929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild hypothermia enhances the neuroprotective effects of FK506 and expands its therapeutic window following transient focal ischemia in rats.
    Nito C; Kamiya T; Ueda M; Arii T; Katayama Y
    Brain Res; 2004 May; 1008(2):179-85. PubMed ID: 15145754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of oxygen therapy on brain damage and cerebral pO(2) in transient focal cerebral ischemia in the rat.
    Hou H; Grinberg O; Williams B; Grinberg S; Yu H; Alvarenga DL; Wallach H; Buckey J; Swartz HM
    Physiol Meas; 2007 Aug; 28(8):963-76. PubMed ID: 17664686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of zonisamide, an antiepileptic drug, against transient focal cerebral ischemia with middle cerebral artery occlusion-reperfusion in rats.
    Minato H; Kikuta C; Fujitani B; Masuda Y
    Epilepsia; 1997 Sep; 38(9):975-80. PubMed ID: 9579935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat.
    Candelario-Jalil E; González-Falcón A; García-Cabrera M; León OS; Fiebich BL
    Brain Res; 2004 May; 1007(1-2):98-108. PubMed ID: 15064140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcineurin inhibitors FK506 and SDZ ASM 981 alleviate the outcome of focal cerebral ischemic/reperfusion injury.
    Bochelen D; Rudin M; Sauter A
    J Pharmacol Exp Ther; 1999 Feb; 288(2):653-9. PubMed ID: 9918571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats.
    Hung YC; Chen TY; Lee EJ; Chen WL; Huang SY; Lee WT; Lee MY; Chen HY; Wu TS
    J Pineal Res; 2008 Nov; 45(4):459-67. PubMed ID: 18624955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of ischemic brain edema and cerebrovascular injury after ischemic preconditioning in the rat.
    Masada T; Hua Y; Xi G; Ennis SR; Keep RF
    J Cereb Blood Flow Metab; 2001 Jan; 21(1):22-33. PubMed ID: 11149665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.